SLC5A2 and hydrops fetalis: If HF medical therapy is initiated prior to delivery, it must be tailored to avoid teratogenic effects to the fetus.63,66,68 Most standard HF medications can be utilized while breastfeeding; however, no safety information is currently available for newer agents such as sacubitril-valsartan or sodium-glucose cotransporter 2 inhibitors.